Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Harold S Javitz

Showing results (31-40 of 54) with videos related to

Pageof 6
Sort By:
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 16, 2004
Return on investment of different combinations of bupropion SR dose and behavioral treatment for smoking cessation in a health care setting: an employer's perspectiveHarold S Javitz, Gary E Swan, Susan M Zbikowski, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 5, 2009
Nicotine withdrawal sensitivity, linkage to chr6q26, and association of OPRM1 SNPs in the SMOking in FAMilies (SMOFAM) sampleJill Hardin, Yungang He, Harold S Javitz, et al.
Frontiers in Public Health|March 28, 2024
Delayed effects of radiation exposure in a C57L/J mouse model of partial body irradiation with ~2.5% bone marrow shieldingTyler Beach, James Bakke, J Tyson McDonald, et al.
Advanced Biosystems|April 16, 2020
Engineered Ovarian Cancer Cell Lines for Validation of CAR T Cell FunctionClaire E Repellin, Priya Ganesan, Javier F Alcudia, et al.
The American Journal of Managed Care|March 23, 2004
Cost-effectiveness of different combinations of bupropion SR dose and behavioral treatment for smoking cessation: a societal perspectiveHarold S Javitz, Gary E Swan, Susan M Zbikowski, et al.
BMC Public Health|September 9, 2015
Total Exposure Study Analysis consortium: a cross-sectional study of tobacco exposuresAndrew W Bergen, Ruth Krasnow, Harold S Javitz, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|February 26, 2011
Adherence to varenicline in the COMPASS smoking cessation intervention trialSheryl L Catz, Lisa M Jack, Jennifer B McClure, et al.
Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine|April 23, 2019
Six Month Abstinence Heterogeneity in the Best Quit StudyHarold S Javitz, Terry M Bush, Jennifer C Lovejoy, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|December 6, 2012
The DRD4 exon III VNTR, bupropion, and associations with prospective abstinenceAndrew W Bergen, Harold S Javitz, Li Su, et al.
Radiation Research|April 9, 2026
Impact of Dose Administration Schedule and Orthovoltage X-ray Beam Quality on Survival and Dose Response Relationships in C57BL/6J Mouse Models of Acute Radiation SyndromeTyler Beach, Tyson J McDonald, Autumn Rassmusen, et al.
Pageof 6

Showing results (31-40 of 54) with videos related to

Sort By:
Pageof 6
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 16, 2004
Return on investment of different combinations of bupropion SR dose and behavioral treatment for smoking cessation in a health care setting: an employer's perspectiveHarold S Javitz, Gary E Swan, Susan M Zbikowski, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 5, 2009
Nicotine withdrawal sensitivity, linkage to chr6q26, and association of OPRM1 SNPs in the SMOking in FAMilies (SMOFAM) sampleJill Hardin, Yungang He, Harold S Javitz, et al.
Frontiers in Public Health|March 28, 2024
Delayed effects of radiation exposure in a C57L/J mouse model of partial body irradiation with ~2.5% bone marrow shieldingTyler Beach, James Bakke, J Tyson McDonald, et al.
Advanced Biosystems|April 16, 2020
Engineered Ovarian Cancer Cell Lines for Validation of CAR T Cell FunctionClaire E Repellin, Priya Ganesan, Javier F Alcudia, et al.
The American Journal of Managed Care|March 23, 2004
Cost-effectiveness of different combinations of bupropion SR dose and behavioral treatment for smoking cessation: a societal perspectiveHarold S Javitz, Gary E Swan, Susan M Zbikowski, et al.
BMC Public Health|September 9, 2015
Total Exposure Study Analysis consortium: a cross-sectional study of tobacco exposuresAndrew W Bergen, Ruth Krasnow, Harold S Javitz, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|February 26, 2011
Adherence to varenicline in the COMPASS smoking cessation intervention trialSheryl L Catz, Lisa M Jack, Jennifer B McClure, et al.
Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine|April 23, 2019
Six Month Abstinence Heterogeneity in the Best Quit StudyHarold S Javitz, Terry M Bush, Jennifer C Lovejoy, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|December 6, 2012
The DRD4 exon III VNTR, bupropion, and associations with prospective abstinenceAndrew W Bergen, Harold S Javitz, Li Su, et al.
Radiation Research|April 9, 2026
Impact of Dose Administration Schedule and Orthovoltage X-ray Beam Quality on Survival and Dose Response Relationships in C57BL/6J Mouse Models of Acute Radiation SyndromeTyler Beach, Tyson J McDonald, Autumn Rassmusen, et al.
Pageof 6